Raha, S.; Dutta, D.; Paidi, R.K.; Pahan, K.
Correction: Raha et al. Lipid-Lowering Drug Gemfibrozil Protects Mice from Tay-Sachs Disease via Peroxisome Proliferator-Activated Receptor α. Cells 2023, 12, 2791. Cells 2024, 13, 1374.
https://doi.org/10.3390/cells13161374
AMA Style
Raha S, Dutta D, Paidi RK, Pahan K.
Correction: Raha et al. Lipid-Lowering Drug Gemfibrozil Protects Mice from Tay-Sachs Disease via Peroxisome Proliferator-Activated Receptor α. Cells 2023, 12, 2791. Cells. 2024; 13(16):1374.
https://doi.org/10.3390/cells13161374
Chicago/Turabian Style
Raha, Sumita, Debashis Dutta, Ramesh K. Paidi, and Kalipada Pahan.
2024. "Correction: Raha et al. Lipid-Lowering Drug Gemfibrozil Protects Mice from Tay-Sachs Disease via Peroxisome Proliferator-Activated Receptor α. Cells 2023, 12, 2791" Cells 13, no. 16: 1374.
https://doi.org/10.3390/cells13161374
APA Style
Raha, S., Dutta, D., Paidi, R. K., & Pahan, K.
(2024). Correction: Raha et al. Lipid-Lowering Drug Gemfibrozil Protects Mice from Tay-Sachs Disease via Peroxisome Proliferator-Activated Receptor α. Cells 2023, 12, 2791. Cells, 13(16), 1374.
https://doi.org/10.3390/cells13161374